SynthesisFrontiers in neurology2022

Safety and efficacy of tyrosine kinase inhibitors for the treatment of multiple sclerosis: A systematic review and meta-analysis from randomized controlled trials.

Zeya Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.